Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.

Kousar, Kousain; Naseer, Faiza; Abduh, Maisa Siddiq; Anjum, Sadia; Ahmad, Tahir

Kousar, Kousain; Naseer, Faiza; Abduh, Maisa Siddiq; Anjum, Sadia; Ahmad, Tahir.

Afiliação

Kousar K; Industrial Biotechnology, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
Naseer F; Industrial Biotechnology, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
Abduh MS; Shifa College of Pharmaceutical Sciences, Shifa Tameer e Millat University, Islamabad, Pakistan.
Anjum S; Immune Responses in Different Diseases Research Group, Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmad T; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.

Front Immunol ; 15: 1391710, 2024.

Article em En | MEDLINE | ID: mdl-38529281